RU2014119323A - A method for predicting the risk of atrial fibrillation in patients with cardiovascular disease - Google Patents
A method for predicting the risk of atrial fibrillation in patients with cardiovascular disease Download PDFInfo
- Publication number
- RU2014119323A RU2014119323A RU2014119323A RU2014119323A RU2014119323A RU 2014119323 A RU2014119323 A RU 2014119323A RU 2014119323 A RU2014119323 A RU 2014119323A RU 2014119323 A RU2014119323 A RU 2014119323A RU 2014119323 A RU2014119323 A RU 2014119323A
- Authority
- RU
- Russia
- Prior art keywords
- patients
- atrial fibrillation
- risk
- predicting
- cardiovascular disease
- Prior art date
Links
- 206010003658 Atrial Fibrillation Diseases 0.000 title claims abstract 5
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract 3
- 102000004889 Interleukin-6 Human genes 0.000 claims abstract 6
- 108090001005 Interleukin-6 Proteins 0.000 claims abstract 6
- 229940100601 interleukin-6 Drugs 0.000 claims abstract 6
- 108010074051 C-Reactive Protein Proteins 0.000 claims abstract 2
- 102100032752 C-reactive protein Human genes 0.000 claims abstract 2
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract 2
- 230000007170 pathology Effects 0.000 claims abstract 2
- 210000002966 serum Anatomy 0.000 claims abstract 2
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Способ прогнозирования риска развития фибрилляции предсердий у пациентов с сердечно-сосудистой патологией, заключающийся в том, что в сыворотке крови пациента определяют концентрацию интерлейкина-6 (ИЛ-6) и/или С-реактивного протеина (СРП) и при значении ИЛ-6>3 пг/мл и/или СРП>3,6 мг/л прогнозируют повышенный риск развития фибрилляции предсердий у пациентов с сердечно-сосудистой патологией.A method for predicting the risk of developing atrial fibrillation in patients with cardiovascular pathology, which consists in determining the concentration of interleukin-6 (IL-6) and / or C-reactive protein (SRP) in the patient’s blood serum and at a value of IL-6> 3 pg / ml and / or PSA> 3.6 mg / L predict an increased risk of developing atrial fibrillation in patients with cardiovascular disease.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014119323A RU2014119323A (en) | 2014-05-13 | 2014-05-13 | A method for predicting the risk of atrial fibrillation in patients with cardiovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014119323A RU2014119323A (en) | 2014-05-13 | 2014-05-13 | A method for predicting the risk of atrial fibrillation in patients with cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014119323A true RU2014119323A (en) | 2016-01-10 |
Family
ID=55071790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014119323A RU2014119323A (en) | 2014-05-13 | 2014-05-13 | A method for predicting the risk of atrial fibrillation in patients with cardiovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2014119323A (en) |
-
2014
- 2014-05-13 RU RU2014119323A patent/RU2014119323A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201792497A1 (en) | ANTIBODIES TO GITR FOR DIAGNOSIS OF MALIGNANT TUMOR | |
| JP2016526167A5 (en) | ||
| RU2014119323A (en) | A method for predicting the risk of atrial fibrillation in patients with cardiovascular disease | |
| RU2014113841A (en) | METHOD FOR EARLY DIAGNOSTICS OF ENDOGENOUS INTOXICATION | |
| JP2015503106A5 (en) | ||
| ES2521841B1 (en) | Diagnostic procedure and prognosis of chronic kidney disease in a human subject | |
| RU2014119325A (en) | A method for predicting the risk of chronic atrial fibrillation in patients with cardiovascular disease | |
| RU2014125620A (en) | METHOD FOR PREDICTING STOMATITIS MANIFESTATIONS IN PATIENTS WITH ACUTE LEUKOSIS TO CHANGE THE CONTENT OF ANTIBODIES TO TRANSLUTAMINASES OF CLASSES OF IMMUNOGLOBULINS A AND G IN ORAL LIQUID | |
| UA108318U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA111000U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA108317U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA110999U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA109603U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA111436U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA108291U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA110997U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA111006U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA110963U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA97041U (en) | METHOD OF FORECASTING FRAGMENT FRAGMENT | |
| UA109533U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA108724U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA104644U (en) | The method of diagnosis of inflammatory activity and threats progression of pulmonary sarcoidosis | |
| UA112743U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA111008U (en) | METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT | |
| UA81217U (en) | Method for prediction of development of false joint |